Hvsen Biotechnology Co., Ltd.
Status: Publicly traded
Direct answer
Hvsen Biotechnology Co., Ltd. is publicly traded on SHZ under the ticker 300871.SZ.
Hvsen Biotechnology Co., Ltd. is a company based in Wuhan, China, that focuses on the global research, development, and manufacturing of macrolide active pharmaceutical ingredients (APIs) and finished drug products. The company's diverse product portfolio features tylvalosin, offered in both raw material form and various preparations, along with florfenicol preparations and a broader selection of other...
Can you invest in Hvsen Biotechnology Co., Ltd.?
Yes. Hvsen Biotechnology Co., Ltd. is publicly traded on SHZ under the ticker 300871.SZ.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Hvsen Biotechnology Co., Ltd.
Detailed equity research is provided by MarketSnap.